Agios Pharmaceuticals, Inc. (AGIO)
Company Info
| ISIN | US00847X1046 |
|---|---|
| CUSIP | 00847X104 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $1.66B |
|---|---|
| EPS | -$6.33 |
| Revenue (TTM) | $26.82M |
| Gross Profit (TTM) | $12.54M |
| EBITDA (TTM) | -$384.86M |
| Year Range | $19.80 - $35.50 |
| Target Price | $42.80 |
| Short % | 11.89% |
| Short Ratio | 9.54 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: AGIO vs. VEXMX, AGIO vs. PFE, AGIO vs. MO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Agios Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Agios Pharmaceuticals, Inc. had a return of 42.21% year-to-date (YTD) and 43.30% in the last 12 months. Over the past 10 years, Agios Pharmaceuticals, Inc. had an annualized return of -2.20%, while the S&P 500 had an annualized return of 10.46%, indicating that Agios Pharmaceuticals, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 42.21% | 5.84% |
| 1 month | 8.98% | -2.98% |
| 6 months | 52.48% | 22.02% |
| 1 year | 43.30% | 24.47% |
| 5 years (annualized) | -11.04% | 11.44% |
| 10 years (annualized) | -2.20% | 10.46% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.57% | 42.88% | -9.53% | |||||||||
| 2023 | -9.77% | -15.11% | 5.81% | 0.18% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Agios Pharmaceuticals, Inc.(AGIO)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Agios Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Agios Pharmaceuticals, Inc. was 87.36%, occurring on Jun 14, 2022. The portfolio has not yet recovered.
The current Agios Pharmaceuticals, Inc. drawdown is 76.54%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -87.36% | Jan 15, 2015 | 1867 | Jun 14, 2022 | — | — | — |
| -51.6% | Oct 7, 2013 | 36 | Nov 25, 2013 | 33 | Jan 14, 2014 | 69 |
| -38.02% | Jan 16, 2014 | 12 | Feb 3, 2014 | 23 | Mar 7, 2014 | 35 |
| -34.2% | Apr 10, 2014 | 28 | May 20, 2014 | 22 | Jun 20, 2014 | 50 |
| -32.91% | Jun 23, 2014 | 18 | Jul 17, 2014 | 48 | Sep 24, 2014 | 66 |
Volatility
Volatility Chart
The current Agios Pharmaceuticals, Inc. volatility is 10.84%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |